Haemonetics Corporation (HAE)
NYSE: HAE · Real-Time Price · USD
63.32
+1.08 (1.74%)
Feb 27, 2026, 4:00 PM EST - Market closed

Haemonetics Stock Forecast

Stock Price Forecast

The 8 analysts with 12-month price forecasts for Haemonetics stock have an average target of 86, with a low estimate of 74 and a high estimate of 100. The average target predicts an increase of 35.82% from the current stock price of 63.32.

Analyst Consensus: Buy
Target Low Average Median High
Price $74 $86 $88 $100
Change +16.87% +35.82% +38.98% +57.93%

Analyst Ratings

The average analyst rating for Haemonetics stock from 9 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Sep '25Oct '25Nov '25Dec '25Jan '26Feb '26
Strong Buy 223111
Buy 555555
Hold 111333
Sell 000000
Strong Sell 000000
Total 889999

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Citigroup
Citigroup
Hold
Maintains
$88$75
Hold Maintains $88$75 +18.45% Feb 6, 2026
Mizuho
Mizuho
Buy
Maintains
$90$80
Buy Maintains $90$80 +26.34% Feb 6, 2026
Barrington Research
Barrington Research
Buy
Maintains
$93$94
Buy Maintains $93$94 +48.45% Feb 6, 2026
BTIG
BTIG
Strong Buy
Reiterates
$88
Strong Buy Reiterates $88 +38.98% Feb 6, 2026
Barrington Research
Barrington Research
Buy
Maintains
$93
Buy Maintains $93 +46.87% Feb 2, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
1.34B
from 1.36B
Decreased by -1.68%
Revenue Next Year
1.41B
from 1.34B
Increased by 5.46%
EPS This Year
4.96
from 3.31
Increased by 49.93%
EPS Next Year
5.49
from 4.96
Increased by 10.61%
Fiscal Year FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Apr 3, 2021 Apr 2, 2022 Apr 1, 2023 Mar 30, 2024 Mar 29, 2025 Mar 31, 2026 Mar 31, 2027
Revenue
870.46M993.20M1.17B1.31B1.36B1.34B1.41B
Revenue Growth
-11.94%14.10%17.67%12.01%3.96%-1.68%5.46%
EPS
1.550.842.242.293.314.965.49
EPS Growth
4.73%-45.81%166.67%2.23%44.54%49.93%10.61%
Forward PE
-----12.7611.54
No. Analysts -----1211
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202620272028
High 1.4B 1.5B
Avg 1.3B 1.4B
Low 1.3B 1.4B

Revenue Growth

Revenue Growth 202620272028
High
2.7%
10.7%
Avg
-1.7%
5.5%
Low
-5.1%
1.3%

EPS Forecast

EPS 202620272028
High 5.20 5.90
Avg 4.96 5.49
Low 4.75 5.01

EPS Growth

EPS Growth 202620272028
High
57.0%
18.9%
Avg
49.9%
10.6%
Low
43.6%
0.9%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.